Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01234077 · ClinicalTrials.gov registry record · NA
Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device
A NA study of Sleep Disorder, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT01234077: Completed NA study of Sleep Disorder, sponsored by National Jewish Health.
NCT01234077 is a NA study of Sleep Disorder that has completed, run by National Jewish Health. The registered enrollment target is 50 participants, below the 160-participant average among 22 other Sleep Disorder trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01234077, a NA study of Sleep Disorder, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not approved this device for use except in a research setting. The purposes of this study are to: a) determine if the ECG data collected using the CPC M1 device is at least as good as the ECG data collected during a diagnostic, in-lab polysomnogram (PSG) (or sleep study) and b) determine if in-home monitoring with the device will provide similar results compared to an in-lab PSG.
Primary Outcome
Does the ECG-based data obtained from a portable device correlate to a similar analysis of simultaneously recorded ECG data obtained from standard polysomnography?
Conditions Studied
Interventions
- DEVICE CPC M1
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT01234077 record still lists
NCT01234077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 160-participant average among 22 other Sleep Disorder trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Sleep Disorder appearing as the primary indexed condition, and to 1 intervention - of which CPC M1 is the first listed.
NCT01234077 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01234077 about?
NCT01234077 is a clinical study titled "Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device". Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not approved this device for use except in a research setting. The purposes of this study are to: a) determi...
What is the current status of trial NCT01234077?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2010-03. Estimated completion is 2010-09.
What conditions does trial NCT01234077 study?
This clinical trial studies the following conditions: Sleep Disorder.
What interventions are being tested in trial NCT01234077?
The interventions under investigation include: CPC M1 (DEVICE).
Who is sponsoring clinical trial NCT01234077?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01234077 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01234077's enrollment target sits among peer trials
50 15th of 22 higher than 7 of 22 other Sleep Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NIA_Improving Function and Well-being by Improving Patient Memory: Transdiagnostic Sleep and Circadian Treatment
RECRUITING · NA
-
Home Apnea Testing in CHildren Trial
RECRUITING · NA
-
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
RECRUITING · NA
-
Pilot Study of BCAA on Sleep
RECRUITING · NA
-
Evaluation of Hypoglossal Nerve Stimulation in Humans With Obstructive Sleep Apnea
COMPLETED · NA
-
The Yoga and Insomnia Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia